Vitrolife AB 

Vitrolife AB (publ) is a medical technology firm focused on the development, production, and commercialization of a wide array of products for assisted reproductive procedures. Its extensive product range encompasses specialized instruments such as oocyte retrieval needles and micromanipulation pipettes, alongside crucial consumables like sperm processing solutions, IVF culture media and oil, general labware, incubators, cryopreservation materials, and offerings for preimplantation genetic testing. Furthermore, the company supplies sophisticated technological platforms, including the EmbryoScope and Primo Vision time-lapse embryo monitoring systems, complete with compatible dishes and analytical tools. Other advanced solutions include Octax laser and imaging systems, as well as environmental control devices like log and guard systems and wireless sensors. Vitrolife maintains a significant global presence, with operations spanning Europe, the Middle East, Africa, Asia, the Japan and Pacific regions, and both North and South America. The company, headquartered in Gothenburg, Sweden, was established in 1994, originally operating under the name Scandinavian IVF Science before adopting its current identity as Vitrolife AB (publ) in 1998.